Rhaeos, a 2022 RISE Founder and Rosenman Innovator, completed a $10.5M Series A funding round to launch the Hydrocephalus Shunt […]
Hydrocephalus Monitor Taking Shape

Rhaeos, a 2022 RISE Founder and Rosenman Innovator, completed a $10.5M Series A funding round to launch the Hydrocephalus Shunt […]
With the completion of a $15.3 million Series B funding round, Aluna will expand its award-winning lung health management platform […]
Hello Alpha, a virtual primary care group, increases accessibility to women’s healthcare through a medical team specifically trained to address […]
XP Health partners with The Health Benefit Alliance to offer HBAVision, a digital-first vision benefits platform providing affordable eyewear and […]
Verana Health releases study in the OSLI Retina Medical Journal that supports using curated, de-identified real-world data to replicate large-scale […]
Valera Health, a 2021 ADAPT program finalist, has partnered with Cascade Health Alliance and Point32 Health to provide tech-driven mental […]
Avisi Technologies, a 2020 Rosenman Innovator, raised $4.06 million to accelerate clinical development of its VisiPlate product, an ocular implant […]
The FDA recently granted 510(k) clearance to Avenda Health, a Rosenman Innovator company, for its prostate cancer mapping platform. Using […]
Alio, a 2015 Rosenman Innovator, has raised $18 million in a Series C funding round. Specializing in wearable technology for […]
Efemoral Medical, a start-up developing a bioresorbable scaffold designed to treat peripheral arterial disease, closed $4.9M Series A1 fund. The […]